Business EconomyPosted at: Apr 25 2025 1:16AM


Laurus labs Q4FY25 net profit rises 208 pc to Rs 234 cr

Hyderabad, Apr 24 (UNI) Laurus Labs Ltd., a leading research and development driven pharmaceutical and biotech company in India, on Thursday said that its net profit increased 208 per cent to Rs 234 crore for the fourth quarter ended March 31,2025 as against Rs 76 crore for the corresponding quarter of FY24.
The Hyderabad-based Pharma Company’s revenues during the quarter rose 19 per cent to Rs 1,720 crore as compared with Rs 1,440 crore in 4QFY24, a release said here.
For the full year, the company’s profit rose 122 per cent to Rs 358 crore as against Rs 161 crore in FY24, while revenues increased to Rs 5,554 crores in FY25 from Rs 5,041 crore in FY24.

Dr. Satyanarayana Chava, Founder & Chief Executive Officer commented; “We delivered very good Q4 results and continued our transformative progress, reflecting robust demand for our CDMO offerings and meeting complex customer needs, supported by growth in FDF division. These results demonstrate the strength of our business model and give us confidence in our outlook. We are deepening our cooperation with major clients, and augmenting it with promising BD and capacity creation. Our business remains well positioned to evolve into a well-diversified CMO/CDMO company with promising pipeline, enabling several technology platforms and commercial excellence, thanks to team commitment to the unified vision of delivering high quality integrated solution and securing our long-term growth potential.”
VV Ravi Kumar, Executive Director & Chief Financial Officer commented; “Despite the ongoing macroeconomic challenges, we have witnessed a high level of demand for our offerings. For Q4, we delivered Rs 1,720 crore in revenues, growth of 19 per cent and Rs 477 crore EBITDA grew by 84 percent, resulting in 27.7 percent margin. Gross margins remained healthy at 55 percent due to favorable CDMO mix and process optimization measures. The fundamentals of our business remain healthy”.
Overall FY25 results, we have delivered revenues of Rs 5,554 crore , representing 10 percent growth and EBITDA stood at Rs 1,115 crore, growth of 40 percent. The EBITDA margin of 20.1 percent has substantially improved, supported by continuing operating leverage within CDMO business, he said..
Going ahead, we remain confident in our growth expectations as we look forward to executing on long lead programs, new assets ramp up with revenue increasing over FY25 with continued focus on operational excellence. Our capital allocation strategy remains unchanged, prioritizing investments into high value business opportunities, he added.
UNI KNR RN
Please log in to get detailed story.
Tags: #Laurus labs Q4FY25 net profit rises 208 pc to Rs 234 cr
More News

Indo-US Business Summit showcases UP as India’s growth engine

15 Nov 2025 | 2:29 AM

Lucknow, Nov 14 (UNI) The Indo-US Business Summit 2025, held in collaboration with Invest UP and the Indo-American Chamber of Commerce in Lucknow, brought together leading voices from government and industry to spotlight Uttar Pradesh’s accelerating economic momentum and its expanding role in driving India’s growth story.

see more..

TVS InvIT inaugurates Rs 250 cr industrial park

15 Nov 2025 | 1:54 AM

Visakhapatnam (Andhra Pradesh), Nov 14 ((UNI): TVS Infrastructure Trust inaugurated the expanded phase of its flagship Tarkeshwar Industrial & Logistics Park here.

see more..

Capillary Technologies IPO opens at ₹549–₹577

15 Nov 2025 | 1:11 AM

Bengaluru, Nov 14 (UNI) Capillary Technologies India Limited opened its Initial Public Offer (IPO) on Friday, fixing a price band of ₹549 to ₹577 per equity share of face value ₹2.

see more..

Festive demand, GST cut drove record vehicle dispatches in Oct: SIAM

15 Nov 2025 | 12:52 AM

New Delhi, Nov 14 (UNI) India’s automobile sector posted its strongest monthly performance to date in October 2025, with passenger vehicles, two-wheelers, and three-wheelers recording their highest-ever dispatches to dealerships, said SIAM data released today.

see more..

Ajman NuVentures Free Zone achieves strong first-year growth; nearly half new firms Indian

14 Nov 2025 | 11:49 PM

Mumbai, Nov 14 (UNI) The Ajman NuVentures Centre Free Zone (ANCFZ) of the United Arab Emirates has recorded a strong debut year, successfully registering more than 6,500 companies since its establishment in October 2024, marking a significant milestone in its efforts to attract global investors.

see more..